REVIEW

Immunological memory as a basis for a wise vaccination strategy. A rationale for introducing a comprehensive seroepidemiological surveillance system in Russia

About authors

1 Laboratory of Translational Biomedicine,
N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology, Moscow, Russia

2 Department of Virology, Faculty of Biology,
Lomonosov Moscow State University, Moscow

3 Institute of Molecular Medicine,
I. M. Sechenov First Moscow State Medical University, Moscow, Russia

4 Department of Epidemiology,
N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology, Moscow, Russia

5 N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology, Moscow

Correspondence should be addressed: Vladimir A. Gushchin
ul. Gamalei, d. 18, Moscow, Russia, 123098; moc.liamg@adainawow

About paper

Funding: this paper was prepared with support of the Russian Ministry of Education and Science, project no. RFMEFI60117X0018.

All authors' contribution to this work is equal: selection and analysis of literature, planning of the manuscript's structure, data interpretation, drafting of the manuscript, editing.

Received: 2017-09-24 Accepted: 2017-10-10 Published online: 2017-12-11
|
Percent of World Health Organization (WHO) member states’ residents relative to the total population of WHO member states which include immunization against major vaccine-preventable infections in their immunization schedules (according to WHO [4])
Table 1. Serological surveillance projects
Table 2. Analytical characteristics of multiplex assays for serological studies
Note. CV — coefficient of variance, DT — diphtheria toxin, TT — tetanus toxin, PT — pertussis toxin, FHA — filamentous hemagglutinin, Prn — pertactin.
Table 3. Correlation between MIA and ELISA results (Smits et al., [116])